Rheumatology
The FDA has approved Cyltezo, for the treatment of chronic inflammatory diseases.
There is increasing interest in the use of musculoskeletal ultrasound in pediatric rheumatology.
A study assessed deucravacitinib in patients with active psoriatic arthritis compared with placebo.
Patients with psoriatic arthritis who have enthesitis are more likely to persist on treatment with tofacitinib.
A study analyzed the use of after-visit instructions at rheumatology clinics.
Treatment with guselkumab provided a durable therapeutic benefit to patients with psoriatic arthritis.
Reproductive health outcomes appear to be greatly impacted by the presence of rheumatic diseases.
Between 1990 and 2019, the global incidence of early-onset osteoarthritis doubled.
The FDA has approved tocilizumab-aazg for the treatment of rheumatoid arthritis, among other diseases.
A regimen of nonoperative care prior to surgery for knee osteoarthritis was associated with good adherence.
A case series presented data on the efficacy of CAR T-cell treatment in patients with rheumatic autoimmune disease.
It is critical for physicians to be confident and comfortable in diagnosing and managing knee osteoarthritis.
Advertisement
Expert Interviews in Rheumatology
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
